1. Home
  2. CAL vs SCTX Comparison

CAL vs SCTX Comparison

Compare CAL & SCTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Caleres Inc.

CAL

Caleres Inc.

HOLD

Current Price

$12.77

Market Cap

449.1M

ML Signal

HOLD

Logo Scribe Therapeutics Inc. Common Stock

SCTX

Scribe Therapeutics Inc. Common Stock

N/A

Current Price

$28.06

Market Cap

536.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CAL
SCTX
Founded
1878
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Shoe Manufacturing
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
449.1M
536.5M
IPO Year
1994
2026

Fundamental Metrics

Financial Performance
Metric
CAL
SCTX
Price
$12.77
$28.06
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$15.00
N/A
AVG Volume (30 Days)
543.6K
220.5K
Earning Date
05-28-2026
N/A
Dividend Yield
2.13%
N/A
EPS Growth
N/A
N/A
EPS
2.14
N/A
Revenue
$85,513,000.00
N/A
Revenue This Year
$5.19
N/A
Revenue Next Year
$2.45
N/A
P/E Ratio
$5.57
N/A
Revenue Growth
0.46
N/A
52 Week Low
$8.80
$17.31
52 Week High
$15.04
$39.60

Technical Indicators

Market Signals
Indicator
CAL
SCTX
Relative Strength Index (RSI) 50.11 49.37
Support Level $11.61 $27.41
Resistance Level $14.06 $39.60
Average True Range (ATR) 0.69 3.41
MACD 0.01 -0.40
Stochastic Oscillator 44.36 34.66

Price Performance

Historical Comparison
CAL
SCTX

About CAL Caleres Inc.

Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - Famous Footwear and Brand Portfolio. The Famous Footwear segment is comprised of its Famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. This segment is comprised of wholesale operations that designs, develops, sources, manufactures, markets and distributes branded, licensed and private-label footwear. Geographically, the company generates the majority of its revenue from Domestic operations.

About SCTX Scribe Therapeutics Inc. Common Stock

Scribe Therapeutics Inc is a clinical-stage biotechnology company engaged in the development of in vivo CRISPR-based genetic medicines. Its research and development activities focus on cardiovascular and metabolic diseases, including atherosclerotic cardiovascular disease (ASCVD). The company's product pipeline includes STX-1150, a CRISPR-based product candidate that utilizes its ELXR epigenetic silencing technology.

Share on Social Networks: